753
Participants
Start Date
October 31, 2004
Primary Completion Date
November 30, 2007
Study Completion Date
November 30, 2007
Aripiprazole
10-30 mg oral once daily for 104 weeks
Risperidone Long Acting Injectable (LAI)
25 mg injection every 2 weeks until week 104. Dosage may be increased or decreased in steps of 12.5 mg. Additional oral risperidone can be administered as required until a dose increase becomes effective.
Quetiapine
Oral tablets are titrated from 50 mg daily to 300-400 mg daily in first 4 days. Subsequently treatment is maintained for 104 weeks and dosage can be adjusted with increments or decrements of 25 to 50 mg.
Hall in Tirol
Linz
Neunkirchen
Pleven
Sofia
Sofia Sofia
Osijek
Rijeka
Split
Zagreb
Brno
Lnáře
Opava
Pardubice
Plzen Czechia
Prague
Praha 2 N/A
Uherský Brod
Ústí nad Labem
Middelfart
Vordingborg
Pÿrnu N/A
Tallinn
Tartu
Bron
Brumath
Créteil
Dieppe
Hénin-Beaumont
Mont-Saint-Martin
Poitiers
Reims
Roubaix
Toulouse
Augsburg
Berlin
Bochum
Duisburg
Düsseldorf
Karlstadt am Main
Krefeld
München
Oranienburg
Stralsund
Heraklion -Crete
Thessalonikis
Budapest
Gyõr
Gyula
Kistarcsa
Szeged
Vác
Cork
Dublin
Kerry
Sligo
Jerusalem
Ramat Gan
Tel Aviv
Jelgava
Riga
Alytus
Kaunas
Klaipėda
Šiauliai
Vilnius
Choroszcz
Gdynia Na
Poznan
Warsaw
Coimbra
Porto
Bucharest
Craiova
Iași
Khobar
Košice
Zvolen
Begunje na Gorenjskem
Ljubljana
Ormož
Madrid
Oviedo (Asturias)
Seville
Valencia
Gothenburg
Trollhättan
Ankara Turkey
Bakirkoy/Istanbul N/A
Istanbul
Izmir
Barnet
Barnsley
Hull
Llantrissant
Swansea
Lead Sponsor
Janssen-Cilag International NV
INDUSTRY